Advancing human lung microphysiological systems to model coronavirus infection and test candidate countermeasures
Ended Awarded Last action
- Contract number
- 75N93022F00006
- Awardee
-
University Of Texas Medical Branch At Galveston UEI MSPWVMXXMN76
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,848,326
Award facts
- Contract value 100% obligated
- $1,848,326.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Galveston, TX 77555, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $420,758 | |
| Funding Only Action | $0 | |
| Exercise an Option | $319,313 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,108,255 |
About this award
This federal contract award, valued at $1,848,326.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Texas Medical Branch at Galveston (UTMB) for the advancement of human lung microphysiological systems to model coronavirus infection and test candidate countermeasures. The award is a delivery order under NIAID's Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract, a $146.3 million single-award vehicle.
UTMB, a state-controlled institution of higher learning, has extensive experience supporting federal agencies through research and development efforts, particularly in high-containment laboratory research and infectious disease modeling. Through this contract, UTMB will leverage its specialized capabilities to support the development and evaluation of medical countermeasures against various pathogens, with a focus on infectious disease research and pandemic preparedness. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N93022F00006?
75N93022F00006 was awarded to University Of Texas Medical Branch At Galveston by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 12, 2022.
How much is contract 75N93022F00006 worth?
The government has obligated $1,848,326 on 75N93022F00006.
Is contract 75N93022F00006 an order under another contract?
Yes. 75N93022F00006 is a delivery order under HHSN272201700040I, an indefinite delivery contract, on NIAID Preclinical Models of Infectious Diseases 2017-2024.
Was contract 75N93022F00006 competed?
The extent of competition for 75N93022F00006 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award